XML 19 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Cover
 9 Months Ended
Sep. 30, 2023
Entity Addresses [Line Items]  
Document Type POS AM
Amendment Flag true
Amendment Description This Post-Effective Amendment No. 2 (this “Amendment”) to the Registration Statement on Form S-1 of Mangoceuticals, Inc. (File No. 333- 275993), initially filed on December 11, 2023 and declared effective by the Securities and Exchange Commission on December 14, 2023 (the “Registration Statement”), is being filed to update the prospectus which forms part of the Registration Statement to (a) fill in blanks on the cover page of the prospectus and throughout regarding pricing terms and the offering price of $0.30 per share; (b) reflect that a Plan of Compliance is being filed with Nasdaq on December 18, 2023, and (c) make corresponding updates to the prospectus in connection therewith.
Entity Registrant Name Mangoceuticals, Inc.
Entity Central Index Key 0001938046
Entity Tax Identification Number 87-3841292
Entity Incorporation, State or Country Code TX
Entity Address, Address Line One 15110 N. Dallas Parkway
Entity Address, Address Line Two Suite 600
Entity Address, City or Town Dallas
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75248
City Area Code (214)
Local Phone Number 242-9619
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Business Contact [Member]  
Entity Addresses [Line Items]  
Entity Address, Address Line One 15110 N. Dallas Parkway
Entity Address, Address Line Two Suite 600
Entity Address, City or Town Dallas
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75248
Contact Personnel Name Jacob D. Cohen